Why the study?
Does targeted next-generation sequencing analysis identify genetic causes in autopsy-negative child SUD cases?
Does targeted next-generation sequencing analysis identify genetic causes in autopsy-negative child SUD cases?
Targeted next-generation sequencing, including cardiomyopathy genes, can identify diagnostic variants in at least 6.3% of autopsy-negative sudden unexpected death in children.
No takes yet. Share an insight, caveat, or question.
Supports genetic testing in autopsy-negative child SUD; leaves open prospective validation before clinical adoption.
Dewar et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: